New hope for schizophrenia patients on multiple medications
NCT ID NCT01626885
Summary
This study aimed to test the long-term safety and effectiveness of an investigational drug called MP-214 for people with schizophrenia. It involved 42 participants who were already taking one or more other antipsychotic medications. The main goal was to see how well patients tolerated the drug and if it helped control their symptoms over an extended period.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Study site
Kurayoshi, Tottori, Japan
Conditions
Explore the condition pages connected to this study.